Skip to main content
ARS Home » Southeast Area » Fayetteville, Arkansas » Poultry Production and Product Safety Research » Research » Publications at this Location » Publication #196124

Title: BACTERIOCINS REDUCE CAMPYLOBACTER COLONIZATION AND ALTER GUT MORPHOLOGY IN TURKEY POULTS

Author
item COLE, KIM - UNIVERSITY OF ARKANSAS
item FARNELL, MORGAN - FORMER USDA ARS PPPSR
item Donoghue, Ann - Annie
item Stern, Norman
item SVETOCH, E - SRCAM, RUSSIAN FEDERATION
item ERUSLANOV, B - SRCAM, RUSSIAN FEDERATION
item VOLODINA, L - SRCAM, RUSSIAN FEDERATION
item KOVALEV, Y - SRCAM, RUSSIAN FEDERATION
item PERELYGIN, V - SRCAM, RUSSIAN FEDERATION
item MITSEVICH, E - SRCAM, RUSSIAN FEDERATION
item MITSEVICH, I - SRCAM, RUSSIAN FEDERATION
item LEVCHUK, V - SRCAM, RUSSIAN FEDERATION
item POKHILENKO, V - SRCAM, RUSSIAN FEDERATION
item BORZENKOV, V - SRCAM, RUSSIAN FEDERATION
item SVETOCH, O - SRCAM, RUSSIAN FEDERATION
item KUDRYAVTSEVA, T - SRCAM, RUSSIAN FEDERATION
item REYES-HERRERA, I - UNIVERSITY OF ARKANSAS
item BLORE, P - UNIVERSITY OF ARKANSAS
item SOLIS DE LOS SANTOS, FAUSTO - UNIVERSITY OF ARKANSAS
item DONOGHUE, D - UNIVERSITY OF ARKANSAS

Submitted to: Poultry Science
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 4/25/2006
Publication Date: 9/11/2006
Citation: Cole, K., Farnell, M., Donoghue, A.M., Stern, N.J., Svetoch, E.A., Eruslanov, B.N., Volodina, L.I., Kovalev, Y.N., Perelygin, V.V., Mitsevich, E.V., Mitsevich, I.P., Levchuk, V.P., Pokhilenko, V.D., Borzenkov, V.N., Svetoch, O.E., Kudryavtseva, T.Y., Reyes-Herrera, I., Blore, P.J., Solis De Los Santos, F., Donoghue, D.J. 2006. Bacteriocins reduce campylobacter colonization and alter gut morphology in turkey poults. Poultry Science. 85:1570-1575.

Interpretive Summary: Campylobacter is a leading cause of food borne illness in the United States. Recent evidence has demonstrated that bacteriocins produced by Bacillus circulans and Paenibacillus polymyxa reduce cecal Campylobacter colonization in broiler chickens infected with Campylobacter jejuni. As Campylobacter coli is the most prevalent Campylobacter isolate recovered in turkeys, the objectives of the present study were to evaluate the efficacy of these bacteriocins against C. coli colonization and their influence on the gastrointestinal architecture of young turkeys. In three separate trials, day-of-hatch poults were orally challenged on day 3 with a mixture of three C. coli isolates. On days 10-12 post-hatch, two bacteriocin treatment groups were given free access to feed supplemented with either purified, microencapsulated bacteriocins whereas the positive controls treatment group had access to untreated feed. At the end of the 3 day dosing period, ceca and duodenal loops were collected for analysis. In each of the three separate trials, treatment with either bacteriocin eliminated detectable ceca Campylobacter concentrations versus controls. Duodenum crypt depth and goblet cell numbers were also reduced in turkeys treated with either bacteriocin versus controls. The dynamic reduction in crypt depth and goblet cell density in turkeys dosed with bacteriocin may provide clues to how bacteriocins inhibit enteric Campylobacter.

Technical Abstract: Campylobacter is a leading cause of food borne illness in the United States. Recent evidence has demonstrated that bacteriocins produced by Bacillus circulans and Paenibacillus polymyxa reduce cecal Campylobacter colonization in broiler chickens infected with Campylobacter jejuni. As Campylobacter coli is the most prevalent Campylobacter isolate recovered in turkeys, the objectives of the present study were to evaluate the efficacy of these bacteriocins against C. coli colonization and their influence on the gastrointestinal architecture of young turkeys. In three separate trials, a total of 135 day-of-hatch poults (n= 45/trial) were orally challenged on day 3 with a mixture of three C. coli isolates. On days 10-12 post-hatch, two bacteriocin treatment groups were given free access to feed supplemented with either purified, microencapsulated bacteriocins whereas the positive controls treatment group had access to untreated feed (n=10/treatment group/trial). At the end of the 3 day dosing period, ceca and duodenal loops were collected for analysis. In each of the three separate trials, treatment with either bacteriocin eliminated detectable ceca Campylobacter concentrations versus controls. Duodenum crypt depth and goblet cell numbers were also reduced in turkeys treated with either bacteriocin versus controls. The dynamic reduction in crypt depth and goblet cell density in turkeys dosed with bacteriocin may provide clues to how bacteriocins inhibit enteric Campylobacter.